A comprehensive analysis of the efficacy of Apremilast/Apremilast tablets and how effective they are

The effect of Apremilast/Apremilast tablets is mainly reflected in the treatment of moderate to severe plaque psoriasis, and its efficacy and applicability have been verified through multiple clinical studies.

Apremilast tablets have shown significant efficacy in the treatment of psoriasis. According to clinical research data, a considerable number of patients achieved PASI 75 (Psoriasis Area and Severity Index Improvement 75%) standard after 16 weeks of treatment with apremilast. For example, in a pivotal phase III clinical study involving 1,255 patients with moderate to severe psoriasis, the results showed that 33.1% of patients achieved PASI after treatment with apremilast. 75, while only 5.3% of patients in the placebo group met this criterion.

Apremilast also has a significant improvement effect on psoriasis lesions in special parts such as scalp and nails. This provides new treatment options for patients suffering from psoriasis in these areas.

In addition to improving skin lesions, apremilast can also significantly improve the itching symptoms of psoriasis patients. In related studies, more than 70% of patients' pruritus scores improved by more than 20%, which was significantly higher than the placebo group.

Although Apremilast tablets may cause some side effects, most patients can tolerate these side effects and make adjustments and management under the guidance of a doctor. At the same time, apremilast has a better safety profile in some aspects than some traditional psoriasis treatments.

It should be noted that each patient's condition and constitution are different, so the efficacy and course of treatment with apremilast will also vary. The doctor will adjust the treatment plan according to the patient's specific situation to achieve the best treatment effect.